Recent studies suggest that PINK1 may also have a protective role in multiple liver diseases, including alcoholic liver disease, nonalcoholic steatohepatitis (NASH), and acetaminophen (APAP)-induced liver injury (AILI) [11–13]. Here, PINK1 is linked to metabolic dysfunction-associated steatohepatitis.